홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

[1,2,4]Triazolo[1,5-a]pyridin-2-ylmethanol → HCID 18406885, 화합물

HRID 1016418
노트
인쇄 미리보기

반응식

HRID 1016418 반응식
[N:1]1[C:2]([CH2:10][OH:11])=[N:3][N:4]2[CH:9]=[CH:8][CH:7]=[CH:6][C:5]=12>C(O)C.[Pd]>[N:1]1[C:2]([CH2:10][OH:11])=[N:3][N:4]2[CH2:9][CH2:8][CH2:7][CH2:6][C:5]=12
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 1

HCID 18406865[1,2,4]Triazolo[1,5-a]pyridin-2-ylmethanol

생성물 1

HCID 18406885HCID 18406885, 화합물

시약·촉매·용매 2

HCID 23938Palladium촉매HCID 702Ethanol용매

실험 절차

[1,2,4]Triazolo[1,5-a]pyridin-2-ylmethanol (prepared as described in Example 82, step a)) (150 mg, 1.0 mmol) in ethanol (10 ml) was hydrogenated on a Parr apparatus at 50 psi over 10% palladium on carbon (150 mg) overnight. The catalyst was separated by filtration, then the filtrate was concentrated in vacuo to yield (5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methanol as a white solid (153 mg). Data for the title compound: 1H NMR (360 MHz, CDCl3) δ 1.97 (2H, m), 2.07 (2H, m), 2.90 (2H, t, J=6.3 Hz), 3.00 (1H, br s), 4.13 (2H, t, J=6.0 Hz), 4.70 (2H, s); MS (ES+) m/e 154 [MH]+.

후처리

  1. customThe catalyst was separated by filtration
  2. concentrationthe filtrate was concentrated in vacuo

출처 및 근거

ORD 기록
ord-55670ba7235c4768b7cacd0871701409
출처 데이터셋
uspto-grants-2002_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06476030B1

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트